Sort by
Refine Your Search
-
Category
-
Field
-
: From Mechanisms to Therapies”. In this CRC we aim to understand how plasticity i.e. non-genetic adaptations of the bone marrow niche induced by the disease or therapeutic agents contribute to drug
-
cell sequencing datasets and to combine these data with AI analyses from bone marrow smears. We aim to analyze mechanisms and also to develop new biomarkers for therapy response and resistance. Job-ID
-
center “Cellular Plasticity in Malignant Myeloid Diseases – From Mechanisms to Therapy” and is a close collaboration with the Department of Hematology and other partners in the consortium. Your profile MSc
-
, it is a globally respected institution that also has outstanding economic significance for the Rhine-Neckar metropolitan region. At the Heidelberg Center for Transcultural Studies (HCTS) of Heidelberg
-
of the synthetic peptide in chronic and acute heart failure animal models. The therapeutic peptide is derived from the protein S100A1, which plays a central role in maintaining normal heart function. The synthetic
-
against cardiac diseases. It is based on extensive preliminary work by our working group, which has demonstrated therapeutic effects of the synthetic peptide in chronic and acute heart failure animal models
-
PhD position (f/m/d) “How to regulate the duration of mitosis and control cell fate decisions” Centre for Molecular Biology (ZMBH) Heidelberg University, Germany We are seeking highly motivated PhD
-
), EMBL Heidelberg and the Hopp-Children’s Cancer Center (KiTZ). These include Prof. Andreas Kulozik and Prof. Matthias Hentze as part of the Molecular Medicine Partnership Unit (MMPU) research group
-
Center (DKFZ) Job-ID: V000014054 Field of application: Klinik für Gastroenterologie, Infektionen und Vergiftungen Location: Heidelberg Job Category: Science and teaching Working hours: Part time (65